Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

PHASE3TerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

May 22, 2023

Study Completion Date

May 22, 2023

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DRUG

FlecIH-103

flecainide acetate inhalation solution

Trial Locations (40)

1097

DPC Hospital Egyesitett Szent Istvan es Szent Laszlo Korhaz, Budapest

3010

Hospital General Universitario de Alicante, Alicante

7198

Fundacion Hospital Son Liatzer, Palma de Mallorca

7624

University of PACs, Pécs

8035

Hospital Universitari Vall d'Hebron, Barcelona

10019

Mount Sinal Hospital, New York

10021

Weill Cornell Medical Center, New York

15706

Hospital Santiago De Compostela, Santiago de Compostela

19107

Thomas Jefferson University Hospital, Philadelphia

19611

Reading Hospital, Reading

27401

Nemocnice Slany, Slaný

28034

Hospital Ramon y Cajal, Madrid

28040

Fundacion Jimenez Diaz, Madrid

28046

La Paz Univerisity Hospital, Madrid

28222

Hospital Universitario Puera de Hierro, Madrid

32806

Orlando Health Heart and Vascular Institute and Orlando Regional medical Center, Orlando

33606

Tampa General Hospital; Center of Research Excellence, Tampa

44109

The MetroHealth System, Cleveland

44195

Cleveland Clinic Emergency Department, Cleveland

45267

University of Cincinnati College of Medicine, Cincinnati

47303

IU Health Ball Memorial Hospital, Muncie

47374

Reid Physician Associates, Richmond

54701

EDUMED s.r.o., Náchod

64116

North Kansas City Hospital, Kansas City

66160

University of Kansas Medical Center Research Institute, Kansas City

90806

Memorial Care, Long Beach

95819

UC Davis Medical Center, Davis

06610

Bridgeport Hospital, Bridgeport

07102

Saint Michaels Medical Center, Newark

07450

The Valley Hospital, Inc, Ridgewood

7417 SE

Deventer Ziekenhuis, Deventer

6716RP

Ziekenhuis Gelderse Vallei, Ede

4462 RA

Admiraal de Ruyter Ziekenhuis, Goes

9713 GZ

Universitair Medisch Centrum Groningen (UMCG), Groningen

2035 RC

Spaarne Gasthuis, Haarlem

8934 AD

Medisch Centrum Leeuwarden, Leeuwarden

3582 KE

Diakonessenhuis, Utrecht

5504 DB

Maxima Medisch Centrum, Veldhoven

07-410

Mazowiecki Szpital Specjalistyczny w Ostrolece, Ostrołęka

87-100

Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu, Torun

Sponsors
All Listed Sponsors
lead

InCarda Therapeutics, Inc.

INDUSTRY